Skip to content
Screener

Baxter International BAX Noncontrolling interests in subsidiaries

Noncontrolling interests in subsidiaries at other companies

Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
-$331.57K-6.7%
STERIS logo
STERISSTE
$14.5M+12.4%
Medline, Inc. logo
Medline, Inc.MDLN
$7.51B
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$14.24B+18.2%
Enterprise value$12.45B+17.5%
P/S1.3×+0.2×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The source filing: Baxter International’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:50 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028962
Line itemMarch 31,2026December 31,2025
Common stock in treasury, at cost, 167,047,900 shares in 2026 and 169,213,617 shares in 2025(10,737)(10,873)
Additional contributed capital6,2146,368
Retained earnings13,68513,705
Accumulated other comprehensive loss(3,802)(3,754)
Total Baxter stockholders’ equity6,0436,129
Noncontrolling interests(27)(27)
Total equity6,0166,102
Total liabilities and equity$19,846$20,055

Item 1. Financial Statements (unaudited)

FAQ

What is Baxter International's noncontrolling interests in subsidiaries?
Baxter International (BAX) reported noncontrolling interests in subsidiaries of -$27M in Q1 2026.
How has Baxter International's noncontrolling interests in subsidiaries changed year-over-year?
Baxter International's noncontrolling interests in subsidiaries decreased by 0.0% year-over-year, from -$27M to -$27M.
What is the long-term trend for Baxter International's noncontrolling interests in subsidiaries?
Over 5 years (2020 to 2025), Baxter International's noncontrolling interests in subsidiaries has grown at a -6.1% compound annual growth rate (CAGR), from $37M to -$27M.
What does noncontrolling interests in subsidiaries mean?
This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.

Ask your AI about Baxter International's noncontrolling interests in subsidiaries.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude